subscale scores

Related by string. * subscales . Subscale : Scale cognitive subscale . function subscales . function subscale . Scale Cognitive Subscale . pain subscale . subscale / scor ed . SCORES . www.score . Scores . SCORE . Score : TIME SCORE MAR VISITORS . SCORE Trophy Truck . SCORE Desert Series . Industry Risk Score . Herb Score . Best Original Score . SAT scores . SCORE Counselors . Tecate SCORE Baja * *

Related by context. All words. (Click for frequent words.) 79 subscales 72 subscore 71 NIH CPSI 70 HRQL 70 PANSS 70 HADS 69 Montgomery Åsberg Depression 69 Health Assessment Questionnaire 69 subscores 69 Brief Psychiatric 69 PSQI 69 QoL 69 EQ 5D 68 HRQOL 68 Physical Component 68 Mental Component 68 MMSE score 68 UPDRS 68 symptom severity 68 interrater reliability 67 MADRS 67 bivariate analyzes 67 IBDQ 67 somatic symptoms 67 CORE OM 67 premorbid 67 BMI z 67 euthymic patients 66 MADRS score 66 covariate 66 Global Impression CGI 66 univariate analyzes 66 depressive symptomatology 66 Symptom Checklist 66 Scale PANSS 66 HRQoL 66 YMRS 66 Comorbidity 66 Pearson correlation coefficient 66 BPRS 66 HDRS 66 alexithymia 66 psychometric properties 66 WOMAC pain 66 depressive symptom 66 HAQ DI 65 cognitive affective 65 ANOVA 65 posttreatment 65 Primary endpoints 65 Rating Scale MADRS 65 SF #v# 65 HAM D# 65 logistic regression model 65 MMSE 65 Negative Syndrome 65 logistic regression analyzes 65 affective disorders 65 ADAS cog 65 symptomatology 64 psychosocial functioning 64 psychiatric morbidity 64 Main Outcome Measures 64 p = .# [002] 64 correlation coefficients 64 ANCOVA 64 liver histology 64 HAMD 64 syndromal 64 SGRQ 64 Depressive Symptoms 64 WOMAC 64 Main Outcome Measure 64 multivariate analyzes 64 International Prostate Symptom 64 Depressive symptoms 64 HOMA IR 64 Sociodemographic 64 univariate analysis 64 PANSS scores 64 Neuropsychiatric Inventory 63 Symptom Severity 63 interobserver 63 bivariate 63 comorbid anxiety 63 Acute Physiology 63 APACHE II 63 multiple logistic regression 63 ADCS ADL 63 Alzheimer Disease Assessment 63 Visual Analog Scale 63 Functional Assessment 63 autonomic dysfunction 63 clinically meaningful improvement 63 Index CDAI 63 Rating Scale BPRS 63 QIDS SR 63 Cronbach alpha 63 Y BOCS 63 Disease Activity 63 psychiatric outpatients 63 poststroke 63 apnea hypopnea index 63 sd = 63 euthymic 63 T2DM 63 Montgomery Asberg Depression 63 psychosocial variables 63 bivariate analysis 62 erection hardness 62 Oswestry Disability Index 62 Distress Scale 62 psychopathological symptoms 62 Global Impression 62 virological response 62 Crohn Disease Activity 62 convergent validity 62 IIEF 62 Pain Intensity 62 multivariable analysis 62 intraclass correlation coefficients 62 NIHSS 62 Incontinence Impact Questionnaire 62 Heritability 62 sociodemographic variables 62 Negative Symptoms 62 point Likert scale 62 retest reliability 62 dyspnoea 62 subtests 62 Unified Parkinson Disease 62 Fibromyalgia Impact Questionnaire 62 Symptom severity 62 Clinician Administered PTSD 62 chi squared 62 Visual Analogue Scale VAS 62 confidence intervals CIs 62 meta regression 62 Pain Rating Scale 62 carotid IMT 62 ADAS Cog 62 salivary cortisol 62 Geriatric Depression 62 neurocognitive function 62 posttest 62 DAS# scores 62 somatization disorder 62 Abnormal Involuntary Movement 62 NYHA functional class 62 Child Behavior Checklist 62 extrapyramidal symptoms 61 Secondary endpoints 61 univariate 61 Severity Index 61 Neuropsychological 61 VFQ 61 ± SD 61 depressive symptoms 61 DSM IV diagnosis 61 SSRI SNRI 61 UPDRS motor 61 Score DAS 61 Secondary efficacy endpoints 61 DAS# [002] 61 odds ratios ORs 61 psychiatric comorbidity 61 affective psychoses 61 affective psychosis 61 Univariate analysis 61 Descriptive statistics 61 P = .# 61 preoperative PSA 61 Meta analyzes 61 Wechsler Adult 61 CDAI 61 WOMAC scores 61 sociodemographic characteristics 61 vasomotor 61 Depression Inventory 61 tertiles 61 untreated psychosis 61 antidepressant efficacy 61 metabolite concentrations 61 psychiatric comorbidities 61 Dyspnea 61 ASIA Impairment 61 Wechsler Memory 61 suicide attempters 61 interobserver reliability 61 mRS 61 fasting plasma 61 PANSS total 61 Multivariate analysis 61 emotional lability 61 BPS IC 61 cognitive domains 61 Kruskal Wallis test 60 Rating Scale UPDRS 60 % Confidence Interval 60 subclinical atherosclerosis 60 Neuroticism 60 logistic regressions 60 HAM D 60 schizophreniform disorder 60 posttransplant 60 exploratory endpoints 60 variance ANOVA 60 Neurocognitive 60 comorbid depression 60 Univariate 60 Scale Revised 60 multivariate Cox 60 elevated ALT 60 primary aldosteronism 60 Subscale 60 IRLS 60 #q# deletion syndrome 60 Status Scale EDSS 60 allele frequencies 60 Epworth Sleepiness Scale 60 clinicopathological 60 MMSE scores 60 ADHD RS 60 GH deficiency 60 Psoriasis Area 60 schizophrenia schizoaffective disorder 60 Scale Cognitive Subscale 60 categorical variables 60 Bonferroni correction 60 β = 60 FEV ^ sub 60 postintervention 60 WAIS III 60 Hamilton Rating Scale 60 nondepressed 60 Score DAS# 60 logistic regression 60 PCWP 60 Pearson correlation coefficients 60 plasma cortisol 60 rCBF 60 erythrocyte sedimentation rate 60 Expanded Disability Status 60 Logistic regression 60 meta analytic 60 MetS 60 CI -#.# 59 = #.#-#.# 59 multivariable adjusted 59 Likert 59 nerve conduction velocity 59 HbA 1c 59 intraobserver 59 Female Sexual Function 59 ADCS CGIC 59 Visual Analog 59 IPSS 59 apnea hypopnea 59 neurocognitive functioning 59 psychophysiological 59 % CI #.#-#.# [006] 59 secondary efficacy endpoint 59 APOE genotype 59 albumin excretion rate 59 neurocognition 59 fasting insulin 59 hypersomnia 59 plasma folate 59 chronicity 59 cardiac autonomic 59 subtest 59 inflammatory biomarkers 59 MDRD 59 predictive validity 59 LV ejection fraction 59 State Examination MMSE 59 rs# [004] 59 Ocular Surface Disease 59 rheumatoid factor 59 Outcomes Study 59 albumin excretion 59 #OHD 59 DAS# CRP 59 clinically meaningful improvements 59 pain catastrophizing 59 coronary stenosis 59 State Trait Anxiety 59 covariance 59 Preoperatively 59 Cronbach 59 ± SEM 59 intact parathyroid hormone 59 semiquantitative 59 hyperarousal 59 MSLT 59 thyrotropin levels 59 -#.# ± [002] 59 regression coefficient 59 immunostaining 59 WCST 59 Outcome Measures 59 logistic regression analysis 59 CNS LS 59 multivariable Cox 59 Symptom 59 regression analyzes 59 TEAEs 59 SDQ 59 Brief Pain 58 Beck Anxiety Inventory 58 lymphocyte count 58 LUTS 58 NIHSS score 58 familial aggregation 58 aspartate aminotransferase 58 parkinsonian 58 serum IGF 58 Wilcoxon rank sum 58 Longitudinal studies 58 tryptophan depletion 58 Comorbidities 58 Score IPSS 58 Histologic 58 Depression Scale 58 NNT = 58 LPS induced 58 Structured Clinical 58 neurocognitive deficits 58 dose dependently 58 electrophysiologic 58 generalized estimating 58 μmol L 58 metabolic parameters 58 neuroleptic 58 somatoform disorders 58 highest tertile 58 bioavailable testosterone 58 URTI 58 lowest tertile 58 adiponectin concentrations 58 IIQ 58 NSTEMI 58 FACIT Fatigue 58 seropositivity 58 Postoperative 58 biochemical recurrence 58 umol L 58 comorbidity 58 Visual Analogue Scale 58 endoscopic remission 58 unpaired t 58 subsyndromal 58 Secondary endpoints included 58 urodynamic parameters 58 dysthymia 58 decrements 58 Mania Rating Scale 58 plasma pharmacokinetics 58 plasma glucose concentration 58 EDSS score 58 euthyroid 58 serum HBV DNA 58 serum cortisol 58 biopsy Gleason 58 tic disorders 58 psychiatric inpatients 58 nasal symptom 58 EORTC QLQ C# 58 nausea photophobia 58 adenotonsillectomy 58 promoter polymorphism 58 Kaplan Meier curves 58 HRCT 58 thyroglobulin 58 r2 = 58 Poisson regression 58 ERalpha 58 % CI #.#-#.# [003] 58 neuropsychological functioning 58 multiple linear regression 58 Generalized Anxiety Disorder 58 subjective sleepiness 58 alanine aminotransferase ALT 58 hypochondriasis 58 aminotransferase levels 58 somatization 58 thyrotropin 58 clinicopathological features 58 DSM IV Axis 58 μg liter 58 nonpsychotic 58 overnight polysomnography 58 endometrial thickness 58 clinico pathological 58 Edinburgh Postnatal Depression 58 TNSS 58 58 covariates 58 semistructured interview 58 genotypic resistance 58 nonobese 58 creatinine ratio 58 PANSS Positive 58 STAI 58 interrater 58 Orthostatic Hypotension 58 Mood disorders 58 tertile 58 tHcy 58 urine albumin 58 PSA nadir 58 function subscale 58 extrapyramidal side 58 postoperative complication 58 neuropathologic 58 mania hypomania 57 CC genotype 57 Posttraumatic stress disorder 57 PLMs 57 neuropsychological assessment 57 Pharmacologic 57 undetectable HBV DNA 57 serum concentrations 57 Neuropsychiatric Inventory NPI 57 etiologic 57 Glasgow Coma Scale 57 Suicidal ideation 57 cranial irradiation 57 behavioral disinhibition 57 Rating Scale 57 ADHD Rating Scale 57 hemoglobin Hb 57 SCr 57 glycated hemoglobin 57 SGPT 57 SGOT 57 Global Impression Severity 57 left ventricular diastolic 57 plasma leptin 57 ROC curves 57 DSM IV TR 57 leukocyte counts 57 airway responsiveness 57 fructosamine 57 pharmacodynamic parameters 57 SGAs 57 Rosenberg Self Esteem 57 HBeAg 57 KOOS 57 spirometric 57 male Wistar rats 57 inotropic 57 conditional logistic regression 57 Anxiety Scale 57 nighttime awakenings 57 DLQI 57 HbA 1c levels 57 % CI #.#-#.# [008] 57 Subgroup analysis 57 â ‰ ¥ 57 AUCs 57 Comorbid 57 aspartate aminotransferase AST 57 Interrater reliability 57 P ≤ 57 probands 57 logistic regression models 57 platelet reactivity 57 lupus anticoagulant 57 bladder carcinoma 57 Anxiety Depression 57 mean ± SEM 57 daytime somnolence 57 Injury Severity Score 57 Stroke Scale NIHSS 57 baseline HbA1c 57 colorectal adenoma 57 Score TOS 57 FACIT 57 glycosylated hemoglobin HbA1c 57 diabetes mellitus DM 57 oxygen desaturation 57 methacholine challenge 57 neuropathological 57 intraclass correlation coefficient 57 histopathological 57 SELENA SLEDAI 57 mRNA expression 57 abdominal adiposity 57 5 HTTLPR genotype 57 lymphocyte counts 57 Exclusion criteria 57 laboratory abnormalities 57 adjunctive placebo 57 neurologic impairment 57 LDL HDL 57 perfusion abnormalities 57 Diagnostic Interview 57 ROSC 57 echocardiographic parameters 57 serum testosterone 57 anthropometric measures 57 psychoeducation 57 serum ALT 57 serum lipid levels 57 somatostatin analog 57 serologically active patients 57 hippocampal volume 57 Logistic regression analysis 57 nonfatal MI 57 serum leptin 57 atherothrombotic disease 57 prospectively defined 57 Likert scale 57 p = #.# [003] 57 plasma lipids 57 p = #.# [002] 57 mg BID dose 57 anthropometric measurements 57 μg dl 57 Polymorphism 57 hematological parameters 57 transaminase elevations 57 randomized controlled trials RCTs 57 multivariate logistic regression 57 comorbid 57 pressor response 57 arterial oxygen saturation 57 amnestic MCI 57 actigraphy 57 Insulin sensitivity 56 McGill Pain Questionnaire 56 alanine aminotransferase 56 NYHA 56 rhinoconjunctivitis 56 leukocyte count 56 HBeAg negative patients 56 Multiple logistic regression 56 pain subscale 56 ALT elevations 56 MBq 56 F FDG PET 56 CFQ R 56 triiodothyronine 56 lipid parameters 56 symptom exacerbation 56 CR nPR 56 neurocognitive impairment 56 comorbid disorders 56 MCID 56 neuropsychological deficits 56 HbA 1C 56 plasma homocysteine 56 Cardiotoxicity 56 NPRS 56 proband 56 periprocedural MI 56 Secondary endpoints include 56 Depression Inventory BDI 56 IL 1ß 56 schizotypal traits 56 acetabular dysplasia 56 nonexposed 56 Haplotype 56 allostatic load 56 timepoints 56 CHD mortality 56 Inventory BPI 56 preoperatively 56 heterozygotes 56 CDAI score 56 neurological abnormalities 56 serum PTH 56 psychopathology 56 mu opioid 56 nondiabetic patients 56 histological subtype 56 visceral adiposity 56 serum folate concentrations 56 serum estradiol 56 aminotransferase 56 eNO 56 CIBIC plus 56 Multivariate logistic regression 56 amygdala reactivity 56 unipolar depression 56 perioperative complications 56 prevalences 56 SRBD 56 hypoglycemic events 56 CLBP 56 acute subacute 56 sociodemographic factors 56 Subtypes 56 sociodemographic 56 CPAP adherence 56 somatic complaints 56 homozygotes 56 CHADS 56 CIN2 + 56 Histological 56 LVEF 56 % CI #.#-#.# [007] 56 Urogenital Distress Inventory 56 Severity Index PASI 56 Hopkins Symptom Checklist 56 circadian genes 56 ABL1 56 angiographically 56 negative affectivity 56 daytime alertness 56 Assessment Questionnaire 56 AST ALT 56 prolactin elevation 56 Baseline characteristics 56 locomotor activity 56 T1DM 56 Predictors 56 Scale EDSS score 56 atherogenic dyslipidemia 56 State Exam MMSE 56 neuroimaging studies 56 serum bilirubin 56 Subgroup analyzes 56 artery occlusion 56 multivariable analyzes 56 left ventricular LV 56 lumbar spine BMD 56 enthesitis 56 nmol l 56 Heterogeneity 56 polyarticular 56 glomerular filtration rate 56 fasting serum 56 detrusor 56 virologic response 56 urinary N telopeptide 56 neuropsychiatric symptoms 56 gene polymorphisms 56 autistic traits 56 Depression Rating Scale 56 retrospective cohort 56 REYATAZ r arm 56 Mini Mental 56 neuroanatomical 56 bronchial responsiveness 56 Kruskal Wallis 56 Cognitive behavioral 56 ventricular myocardium 56 CCyR 56 nonsignificant 56 macroalbuminuria 56 PaO 2 56 premenopause 56 CD4 CD8 56 Cardiorespiratory fitness 56 hepatic cirrhosis 56 femoral neck BMD 56 Multiple linear regression 56 Anthropometric 56 aged ≥ 56 Index HAQ DI 56 Symptom Scale 56 tipranavir r 56 DSM IV diagnoses 56 cerebral perfusion 56 CP CPPS 56 Cytogenetic 56 Stroke Scale 56 Depression Anxiety 56 differential gene expression 56 internalizing behaviors 56 idiopathic Parkinson disease 56 Conscientiousness 56 hemodynamic parameters 56 Assessment Scale 56 elevated creatinine 56 diabetes mellitus hypertension 56 χ 56 symptomatic VTE 56 glycaemia 56 biochemical relapse 55 HbA1c levels 55 cerebral oxygenation 55 nonparametric 55 ^ sup #m 55 serum lipids 55 multivariable logistic regression 55 guideline concordant 55 ug kg 55 schizotypal 55 Echocardiographic 55 elevated LDH 55 Exacerbations 55 PON1 gene 55 IQR 55 SSc 55 Clinical Dementia 55 bronchial hyperresponsiveness 55 nontraumatic 55 CI #.#-#.# [001] 55 hypoglycaemic episodes 55 Beta Amyloid 55 Genotypes 55 somatic symptom 55 F FDG uptake 55 serum retinol 55 confidence interval CI 55 Hemodynamic 55 Hamilton Anxiety Scale 55 akathisia 55 GH deficient 55 bacterial prostatitis 55 serum parathyroid hormone 55 ß = 55 kidney allograft 55 Regression analyzes 55 DAS# remission 55 d dimer 55 ACR# ACR# 55 neurologic complications 55 inhibin B 55 D Dimer 55 Key secondary endpoints 55 tic severity 55 immunoreactivity 55 Non inferiority 55 Difficulties Questionnaire 55 Serum concentrations 55 hip BMD 55 chi ^ sup 55 regression coefficients 55 haematologic 55 corticosteroid dose 55 covariance ANCOVA 55 Scale EDSS 55 psychodynamic psychotherapy 55 ECLS 55 incontinence episodes 55 NAA Cr 55 quartiles 55 COPD exacerbation 55 pairwise comparisons 55 Visual acuity 55 sUA 55 GABRA2 55 rFSH 55 % CI #.#-#.# [005] 55 UPDRS scores 55 ‰ ¥ 55 Cognitive impairment 55 Clinical Outcome 55 hyperactivity inattention 55 subthreshold 55 antenatal depression 55 adjunctive ABILIFY 55 T2 lesions 55 Index FSFI 55 tissue oxygenation 55 airway hyperresponsiveness 55 ACR Pedi 55 methodologic 55 Coronary Artery Calcium 55 Heart Rate Variability 55 Socioeconomic status 55 hyperreflexia 55 Functional Outcomes 55 LV dysfunction 55 COMT genotype 55 hypogonadotropic hypogonadism 55 Preoperative 55 periprocedural 55 polysomnographic 55 APOE e4 55 coronary calcification 55 antibody titer 55 lymphocytosis 55 intima media thickness 55 cis retinoic acid 55 posterior cingulate 55 EDSS scores 55 neurologic dysfunction 55 diabetic polyneuropathy 55 IRLS score 55 hematologic parameters 55 HIV HCV coinfected 55 Diagnostic Criteria 55 nitrotyrosine 55 abdominal pain abdominal discomfort 55 5 HTTLPR 55 Intervention Trial 55 Hcy 55 baseline FEV 55 PDSS 55 Multivariable 55 dysphoric 55 Maslach Burnout Inventory 55 neurophysiologic 55 shorter telomere length 55 attain statistical significance 55 binary logistic regression 55 dose proportionality 55 c Fos 55 Major Depressive Disorder 55 Kaplan Meier analysis 55 definite stent thrombosis 55 comorbid psychiatric 55 vasopressor 55 Lower Limb 55 IL#B 55 serum folate 55 magnetic resonance spectroscopic imaging 55 Hemoglobin A1c 55 ejaculatory control 55 statistically nonsignificant 55 multivariate adjustment 55 MDQ 55 PSA kinetics 55 Correlates 55 hypomanic symptoms 55 PsA 55 Autistic Disorder 55 orthostatic 55 amisulpride 55 Somnolence 55 cortical activation 55 hepatic enzyme 55 hypercalciuria 55 adrenal function 55 β blocker 55 Symptom Score 55 UGT#A# * 55 QOL 55 Scale cognitive subscale 55 dimensional echocardiography 55 NHANES III 55 apolipoproteins 55 Erectile Function 55 CIMZIA TM certolizumab pegol 55 comorbid conditions 55 baroreceptor 55 Cystatin C 55 ACEI 55 55 hyperhomocysteinemia 55 prostate cancer CaP 55 anti Mullerian hormone 55 neutropaenia 55 hypopneas 55 β blockers 55 nmol L. 55 psychiatric diagnoses 55 fractional anisotropy 55 Psychosomatic Research 55 virologic responses 55 anal incontinence 55 p = NS 55 hydroxyvitamin D levels 55 #β estradiol 55 clinically meaningful reductions 55 Primary Endpoint 55 Apgar scores 55 RYGB 55 symptom checklist 55 dexamethasone suppression 55 Subtype 55 histologic findings 55 Cognitive Function 55 sensitivity specificity 55 comorbid diagnoses 55 mIU L 55 enzyme inhibition 55 QTcF 55 Agreeableness 55 hyperlipidaemia 55 postoperative AF 55 apolipoprotein B 55 EEG recordings 55 non affective psychosis 55 NNRTI resistance 55 OSAHS 55 silent myocardial ischemia 55 serum BDNF 55 neuropsychological 55 phosphorylated tau 55 microsatellite instability 55 atherothrombotic 55 RCTs 55 Phenotypic 55 proton MR spectroscopy 55 OGTT 55 Conflict Tactics 55 IPAH 54 extensive metabolizers 54 hyperalgesia 54 HbA1C levels 54 df = 54 achieved statistical significance 54 comorbid psychiatric disorders 54 CLA supplementation 54 Research Diagnostic Criteria 54 PEG IFN 54 Kellgren Lawrence 54 interpersonal psychotherapy 54 prospectively enrolled 54 neurobehavioural 54 postinjury 54 mesalamine granules 54 Ashworth Scale 54 CRp 54 Psychotic Disorders 54 diastolic hypertension 54 posttraumatic 54 TIMP 1 54 Bonferroni 54 serum triglycerides 54 abstinent alcoholics 54 ECOG PS 54 hippocampal atrophy 54 Functioning Scale 54 troponin T 54 uM 54 bulimia nervosa 54 ng dL 54 systolic BP 54 Controlled Trial 54 Obsessive Compulsive Scale 54 BALF 54 transvaginal sonography 54 parkinsonism 54 Numeric Rating Scale 54 Leydig cell 54 cortisol secretion 54 Kaplan Meier curve 54 Prehypertension 54 pyridostigmine 54 CIBIC + 54 inflammatory markers 54 reflux symptoms 54 TC HDL 54 Partial Response 54 serum CRP 54 detrusor overactivity 54 intelligence quotient IQ 54 Interpersonal psychotherapy 54 Subjective 54 GH secretion 54 lesional 54 HLA DR4 54 Pain Inventory 54 explanatory variables 54 CHADS2 54 paricalcitol 54 syndromic 54 endocannabinoid signaling 54 postdischarge 54 Multivariate analysis revealed 54 interindividual variability 54 polysomnogram 54 avoidant personality disorder 54 ictal 54 MS DRGs 54 neurosensory 54 secondary efficacy endpoints 54 Atopic 54 Panic Disorder 54 serum vitamin D 54 mL/min/#.# m 2 54 μg dL 54 prucalopride 54 DRD2 54 Ejection Fraction 54 TT genotype 54 anticholinergic medication 54 mucosal inflammation 54 manic hypomanic 54 symptomatic DVT 54 physiologic parameters 54 SLC#A# [002] 54 serum HCV RNA 54 left ventricular systolic 54 receptor subtypes 54 androgen depletion 54 demonstrated clinically meaningful 54 serum albumin 54 serum triglyceride 54 urodynamic 54 lactate dehydrogenase 54 multivariable 54 OAB symptoms 54 antitrypsin 54 Chronic Illness Therapy 54 SSRI citalopram 54 mentation 54 PUFA intake 54 familial clustering 54 pCR 54 histologic 54 parous women

Back to home page